Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies
- PMID: 12859666
- DOI: 10.1046/j.1471-4159.2003.01862.x
Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies
Abstract
Brain cells are metabolically flexible because they can derive energy from both glucose and ketone bodies (acetoacetate and beta-hydroxybutyrate). Metabolic control theory applies principles of bioenergetics and genome flexibility to the management of complex phenotypic traits. Epilepsy is a complex brain disorder involving excessive, synchronous, abnormal electrical firing patterns of neurons. We propose that many epilepsies with varied etiologies may ultimately involve disruptions of brain energy homeostasis and are potentially manageable through principles of metabolic control theory. This control involves moderate shifts in the availability of brain energy metabolites (glucose and ketone bodies) that alter energy metabolism through glycolysis and the tricarboxylic acid cycle, respectively. These shifts produce adjustments in gene-linked metabolic networks that manage or control the seizure disorder despite the continued presence of the inherited or acquired factors responsible for the epilepsy. This hypothesis is supported by information on the management of seizures with diets including fasting, the ketogenic diet and caloric restriction. A better understanding of the compensatory genetic and neurochemical networks of brain energy metabolism may produce novel antiepileptic therapies that are more effective and biologically friendly than those currently available.
Similar articles
-
Ketone bodies in epilepsy.J Neurochem. 2012 Apr;121(1):28-35. doi: 10.1111/j.1471-4159.2012.07670.x. Epub 2012 Feb 7. J Neurochem. 2012. PMID: 22268909 Free PMC article. Review.
-
Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms.Epilepsy Res. 1999 Dec;37(3):223-32. doi: 10.1016/s0920-1211(99)00074-1. Epilepsy Res. 1999. PMID: 10584972 Review.
-
The ketogenic diet: 1997.Adv Pediatr. 1997;44:297-329. Adv Pediatr. 1997. PMID: 9265974 Review.
-
Reduced glucose utilization underlies seizure protection with dietary therapy in epileptic EL mice.Epilepsy Behav. 2014 Oct;39:48-54. doi: 10.1016/j.yebeh.2014.08.007. Epub 2014 Sep 7. Epilepsy Behav. 2014. PMID: 25200525 Free PMC article.
-
[Therapeutic approach to epilepsy from the nutritional view: current status of dietary treatment].Neurologia. 2007 Oct;22(8):517-25. Neurologia. 2007. PMID: 17641989 Review. Spanish.
Cited by
-
Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models.Ann Neurol. 2009 Apr;65(4):435-47. doi: 10.1002/ana.21603. Ann Neurol. 2009. PMID: 19399874 Free PMC article.
-
Genetic analysis of biological pathway data through genomic randomization.Hum Genet. 2011 May;129(5):563-71. doi: 10.1007/s00439-011-0956-2. Epub 2011 Jan 30. Hum Genet. 2011. PMID: 21279722 Free PMC article.
-
Alterations in Cytosolic and Mitochondrial [U-13C]Glucose Metabolism in a Chronic Epilepsy Mouse Model.eNeuro. 2017 Mar 9;4(1):ENEURO.0341-16.2017. doi: 10.1523/ENEURO.0341-16.2017. eCollection 2017 Jan-Feb. eNeuro. 2017. PMID: 28303258 Free PMC article.
-
Harnessing the power of metabolism for seizure prevention: focus on dietary treatments.Epilepsy Behav. 2013 Mar;26(3):266-72. doi: 10.1016/j.yebeh.2012.09.019. Epub 2012 Oct 27. Epilepsy Behav. 2013. PMID: 23110824 Free PMC article. Review.
-
Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats.J Neurosci. 2007 Oct 31;27(44):12007-11. doi: 10.1523/JNEUROSCI.3163-07.2007. J Neurosci. 2007. PMID: 17978042 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
